-
2023: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting and essays of 2023.
by Cancer Today staff
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
Cancer Today Editors’ Picks: 2023The editors of Cancer Today share the stories that most resonated with readers in 2023.
-
December 15: The Week in Cancer NewsStudy finds breast cancer survivors can opt for less frequent screening, and people with physical disabilities often encounter discrimination in cancer care.
by Thomas Celona
-
Patient Advocates as Research PartnersSpeakers at SABCS discuss how people who have lived with breast cancer can be valuable partners in research.
by Eric Fitzsimmons
-
Understanding Side Effects and the Patient ExperienceResearchers focus on assessing quality of life and toxicity risks in people with breast cancer.
by Thomas Celona
-
Addressing Social Determinants of HealthSpeakers at SABCS discuss measuring and meeting social factors that affect the health and outcomes of breast cancer patients.
by Kevin McLaughlin
-
December 8: The Week in Cancer NewsLess radiation explored in multiple studies at San Antonio Breast Cancer Symposium, and National Cancer Institute writes next precision medicine chapter.
by Marci A. Landsmann
-
Exercise Benefits in Metastatic Breast CancerStudy finds supervised physical activity can help improve quality of life and reduce fatigue among people with metastatic breast cancer.
by Thomas Celona
-
Finding Answers in Prostate CancerPSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
by Sandra Gordon
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
